Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3669665
Author(s) Satalkar, Priya; Elger, Bernice Simone; Shaw, David M.
Author(s) at UniBasel Elger, Bernice Simone
Satalkar, Priya
Shaw, David
Year 2016
Title Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
Journal Science and Engineering Ethics
Volume 22
Number 5
Pages / Article-Number 1255-1276
Keywords Nanotechnology,nanomedicine, ethics
Abstract Nanotechnology, which involves manipulation of matter on a 'nano' scale, is considered to be a key enabling technology. Medical applications of nanotechnology (commonly known as nanomedicine) are expected to significantly improve disease diagnostic and therapeutic modalities and subsequently reduce health care costs. However, there is no consensus on the definition of nanotechnology or nanomedicine, and this stems from the underlying debate on defining 'nano'. This paper aims to present the diversity in the definition of nanomedicine and its impact on the translation of basic science research in nanotechnology into clinical applications. We present the insights obtained from exploratory qualitative interviews with 46 stakeholders involved in translational nanomedicine from Europe and North America. The definition of nanomedicine has implications for many aspects of translational research including: fund allocation, patents, drug regulatory review processes and approvals, ethical review processes, clinical trials and public acceptance. Given the interdisciplinary nature of the field and common interest in developing effective clinical applications, it is important to have honest and transparent communication about nanomedicine, its benefits and potential harm. A clear and consistent definition of nanomedicine would significantly facilitate trust among various stakeholders including the general public while minimizing the risk of miscommunication and undue fear of nanotechnology and nanomedicine.
Publisher Springer Verlag
ISSN/ISBN 1353-3452 ; 1471-5546
edoc-URL http://edoc.unibas.ch/45090/
Full Text on edoc No
Digital Object Identifier DOI 10.1007/s11948-015-9705-6
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/26373718
ISI-Number WOS:000385207100001
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.353 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/04/2024